ESC 365 - Fontan associated liver disease: how does it affect outcome?

ESC Premium Access

Fontan associated liver disease: how does it affect outcome?

Session: Answers to tough questions in adult congenital heart disease

Topic: Aortic valve disease

Speaker: Doctor A. Egbe (Rochester, US)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Alexander Egbe

Mayo Clinic, Rochester (United States of America)

1 presentation

1 follower

3 more presentations in this session

Pulmonary vasodilators in ACHD: what is the evidence?

Speaker: Doctor B. Bouma (Amsterdam, NL)

Management of the failing sub-aortic right ventricle

Speaker: Professor E. Oechslin (Toronto, CA)

Is there a role for CRT in ACHD?

Speaker: Doctor T. Wong (London, GB)

Access the full session

Answers to tough questions in adult congenital heart disease

Speakers: Doctor A. Egbe, Doctor B. Bouma, Professor E. Oechslin, Doctor T. Wong

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources